Terms: = Liver cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
342 results:
1. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
Olaleye OO; Kim DH; Spriggs KA
BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
[TBL] [Abstract] [Full Text] [Related]
2. C-X-C motif chemokine receptor 4 inhibition promotes the effect of plantamajoside in hepatocellular carcinoma.
Sun J; Liu W; Fu H; Li Y; Huang J; Wang Y; Zhu L
Arab J Gastroenterol; 2024 Feb; 25(1):28-36. PubMed ID: 38220479
[TBL] [Abstract] [Full Text] [Related]
3. Highly efficient and chemoselective blocking of free amino group by ortho-phthalaldehyde (OPA) for comprehensive analysis of protein terminome.
Wang T; Wang Z; Wang R; Zhang L; Zhang Y; Lu H
Talanta; 2024 Jan; 267():125262. PubMed ID: 37804787
[TBL] [Abstract] [Full Text] [Related]
4. Domino liver Transplantation for Unresectable Colon cancer liver Metastasis From a Donor With Heterozygous Familial Hyperlipidemia: A Case Report.
Sambommatsu Y; Bruno DA; Imai D; Lee SD; Khan AA; Sharma A; Saeed M; Cotterell AH; Levy MF; Bhati C; Kumaran V
Transplant Proc; 2023 Oct; 55(8):1930-1933. PubMed ID: 37661467
[TBL] [Abstract] [Full Text] [Related]
5. Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation.
Ratti F; Marino R; Olthof PB; Pratschke J; Erdmann JI; Neumann UP; Prasad R; Jarnagin WR; Schnitzbauer AA; Cescon M; Guglielmi A; Lang H; Nadalin S; Topal B; Maithel SK; Hoogwater FJH; Alikhanov R; Troisi R; Sparrelid E; Roberts KJ; Malagò M; Hagendoorn J; Malik HZ; Olde Damink SWM; Kazemier G; Schadde E; Charco R; de Reuver PR; Groot Koerkamp B; Aldrighetti L;
Hepatology; 2024 Feb; 79(2):341-354. PubMed ID: 37530544
[TBL] [Abstract] [Full Text] [Related]
6. Clinical phenotype and genetic function analysis of a rare family with hereditary leiomyomatosis and renal cell carcinoma complicated with Birt-Hogg-Dubé syndrome.
Pan HH; Ruan DD; Wu M; Chen T; Lu T; Gan YM; Wang C; Liao LS; Lin XF; Chen X; Zhu YB; Fang ZT; Yu QH; Yang GK; Ye LF; Luo JW
J Med Genet; 2023 Nov; 60(12):1210-1214. PubMed ID: 37468236
[TBL] [Abstract] [Full Text] [Related]
7. Osimertinib is a dual inhibitor of hepatocellular carcinoma and angiogenesis in an EGFR-independent manner, and synergizes with venetoclax.
Huang Q; He S; Zhan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10727-10735. PubMed ID: 37310474
[TBL] [Abstract] [Full Text] [Related]
8. 68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRI.
Mayerhoefer ME; Raderer M; Weber M; Lamm W; Kiesewetter B; Hacker M; Nics L; Schmitl S; Leithner D; Wester HJ; Haug A
Clin Nucl Med; 2023 Jul; 48(7):557-562. PubMed ID: 37272977
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin-22 promotes the proliferation and migration of hepatocellular carcinoma cells via the phosphoinositide 3-kinase (PI3K/AKT) signaling pathway.
Mansur F; Arshad T; Liska V; Manzoor S
Mol Biol Rep; 2023 Jul; 50(7):5957-5967. PubMed ID: 37264148
[TBL] [Abstract] [Full Text] [Related]
10. Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells.
He M; Liao Q; Liu D; Dai X; Shan M; Yang M; Zhang Y; Zhai L; Chen L; Xiang L; He M; Li S; Chen A; Sun L; Lian J
Biochem Pharmacol; 2023 May; 211():115538. PubMed ID: 37019185
[TBL] [Abstract] [Full Text] [Related]
11. MAEL facilitates metabolic reprogramming and breast cancer progression by promoting the degradation of citrate synthase and fumarate hydratase via chaperone-mediated autophagy.
Zhou L; Ou S; Liang T; Li M; Xiao P; Cheng J; Zhou J; Yuan L
FEBS J; 2023 Jul; 290(14):3614-3628. PubMed ID: 36866961
[TBL] [Abstract] [Full Text] [Related]
12. Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis.
Yang Z; Liu J; Xue F; Zhang L; Xue H; Wu Y; Bai S; Du F; Wang X; Deng W; Song C; Wang K
Ann Hepatol; 2023; 28(2):100898. PubMed ID: 36634747
[TBL] [Abstract] [Full Text] [Related]
13. 13-Acetoxysarcocrassolide induces apoptosis in human hepatocellular carcinoma cells through mitochondrial dysfunction and suppression of the PI3K/AKT/mTOR/p70S6K signalling pathway.
Hsu CM; Lin JJ; Su JH; Liu CI
Pharm Biol; 2022 Dec; 60(1):2276-2285. PubMed ID: 36416062
[TBL] [Abstract] [Full Text] [Related]
14. liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data.
Iliodromiti S; McLaren J; Ghouri N; Miller MR; Dahlqvist Leinhard O; Linge J; Ballantyne S; Platt J; Foster J; Hanvey S; Gujral UP; Kanaya A; Sattar N; Lumsden MA; Gill JMR
Diabetologia; 2023 Jan; 66(1):44-56. PubMed ID: 36224274
[TBL] [Abstract] [Full Text] [Related]
15. Small-molecule High-throughput Screening Identifies an MEK Inhibitor PD198306 that Enhances Sorafenib Efficacy via mcl-1 and BIM in Hepatocellular Carcinoma Cells.
Hong J; Zheng W; Cai X
Comb Chem High Throughput Screen; 2023; 26(7):1364-1374. PubMed ID: 36043792
[TBL] [Abstract] [Full Text] [Related]
16. Bcl-x
Hoffmeister-Wittmann P; Mock A; Nichetti F; Korell F; Heilig CE; Scherr AL; Günther M; Albrecht T; Kelmendi E; Xu K; Nader L; Kessler A; Schmitt N; Fritzsche S; Weiler S; Sobol B; Stenzinger A; Boeck S; Westphalen CB; Schulze-Osthoff K; Trojan J; Kindler T; Weichert W; Spiekermann K; Bitzer M; Folprecht G; Illert AL; Boerries M; Klauschen F; Ochsenreither S; Siveke J; Bauer S; Glimm H; Brors B; Hüllein J; Hübschmann D; Uhrig S; Horak P; Kreutzfeldt S; Banales JM; Springfeld C; Jäger D; Schirmacher P; Roessler S; Ormanns S; Goeppert B; Fröhling S; Köhler BC
Liver Int; 2022 Dec; 42(12):2855-2870. PubMed ID: 35983950
[TBL] [Abstract] [Full Text] [Related]
17. Ursolic acid enhances the antitumor effects of sorafenib associated with mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer.
Li H; Yu Y; Liu Y; Luo Z; Law BYK; Zheng Y; Huang X; Li W
Pharmacol Res; 2022 Aug; 182():106306. PubMed ID: 35714823
[TBL] [Abstract] [Full Text] [Related]
18. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
[TBL] [Abstract] [Full Text] [Related]
19. Alisol B 23-Acetate Increases the Antitumor Effect of Bufalin on liver cancer through Inactivating Wnt/
Ye M; Tang Y; He J; Cao X; Liu J; Kou S; Yang Y; Xue J; Li F
Comput Math Methods Med; 2022; 2022():6249534. PubMed ID: 35572840
[TBL] [Abstract] [Full Text] [Related]
20. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
[Next]
